GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bionomics Ltd (NAS:BNOX) » Definitions » 10-Year ROIIC %

Bionomics (Bionomics) 10-Year ROIIC % : 349.76% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Bionomics 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. Bionomics's 10-Year ROIIC % for the quarter that ended in Jun. 2023 was 349.76%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Bionomics's 10-Year ROIIC % or its related term are showing as below:

BNOX's 10-Year ROIIC % is ranked better than
93.02% of 1361 companies
in the Biotechnology industry
Industry Median: -34.88 vs BNOX: 349.76

Bionomics 10-Year ROIIC % Historical Data

The historical data trend for Bionomics's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionomics 10-Year ROIIC % Chart

Bionomics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
10-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -42.05 0.11 -34.23 -55.22 349.76

Bionomics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
10-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 349.76 -

Competitive Comparison of Bionomics's 10-Year ROIIC %

For the Biotechnology subindustry, Bionomics's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bionomics's 10-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bionomics's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Bionomics's 10-Year ROIIC % falls into.



Bionomics 10-Year ROIIC % Calculation

Bionomics's 10-Year ROIIC % for the quarter that ended in Jun. 2023 is calculated as:

10-Year ROIIC %=10-Year Incremental Net Operating Profit After Taxes (NOPAT)**/10-Year Incremental Invested Capital**
=( -21.32051 (Jun. 2023) - -18.9728238 (Jun. 2013) )/( 15.797 (Jun. 2023) - 25.378 (Jun. 2013) )
=-2.3476862/-9.581
=24.50%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Bionomics  (NAS:BNOX) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Bionomics 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Bionomics's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bionomics (Bionomics) Business Description

Traded in Other Exchanges
Address
200 Greenhill Road, Eastwood, SA, AUS, 5063
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.